We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Clot Removal Dramatically Improves Stroke Outcomes

By HospiMedica International staff writers
Posted on 26 Apr 2015
Print article
The Solitaire FR revascularization device
The Solitaire FR revascularization device (Photo courtesy of COVIDIEN)
Removing obstructing blood clots can significantly improve outcomes for people who suffer acute ischemic stroke, according to a new study.

Researchers at the UCLA Stroke Center (Los Angeles, CA, USA), University Hospital Essen (Germany), and 37 other institutions randomly assigned 196 eligible patients with stroke who were receiving or had received intravenous tissue plasminogen activator (t-PA) to continue with t-PA alone (control group, 98 patients) or to undergo endovascular thrombectomy with a stent retriever within six hours after symptom onset (intervention group, 96 patients). The primary outcome was the severity of global disability at 90 days on the modified Rankin scale.

The study, which was stopped early due to efficacy, showed that in the intervention group the rate of substantial reperfusion at the end of the procedure was 88%, compared to 25%–30% in the control group. Thrombectomy with the stent retriever plus intravenous t-PA also reduced disability at 90 days over the entire range of scores on the modified Rankin scale. Functional independence was higher in the intervention group (60%) than in the control group (35%). There were no significant differences in mortality or symptomatic intracranial hemorrhage. The study was published on April 17, 2015, in the New England Journal of Medicine (NEJM).

“We are very happy to see this decade-long research program result in an important advance for stroke patients. These findings are a paradigm shift — a new era in stroke care — and we are ecstatic,” said global lead author Prof. Jeffrey Saver, MD, director of the UCLA Stroke Center. “We will be able to treat many more patients, who will have much better outcomes. This is a once-in-a-generation advance in acute stroke care.”

“While this won’t help all stroke patients, the ones it will help have the most disabling strokes,” said study coauthor Sidney Starkman, MD, co-director of the UCLA Stroke Center. “Right now, they get t-PA and it helps a third of them, but the other two-thirds end up dependent on others for help or they die.”

For the study, the researchers used the Covidien (Dublin, Ireland) Solitaire FR revascularization device, a mechanical catheter-based thrombectomy system that combines the ability to restore blood flow, administer medical therapy, and retrieve clot in patients experiencing acute ischemic stroke.

Related Links:

UCLA Stroke Center
University Hospital Essen

Gold Supplier
Enteral Feeding Pump
Ceiling Suspension Tubestand
Lem Plus iC
Abdominal Stent Graft Platform
Ovation iX
Multi-Parameter Patient Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
Click here to Register

FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.